DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Ind-Swift Laboratories Limited — Allotment of Securities

NSE 1 hr ago·17 Sept 2026, 12:15 pm

IND Swift Laboratories LT

Ind-Swift Laboratories Limited has informed stock exchanges about the allotment of 70 lakh fully convertible warrants on a preferential basis. This means the company has issued these warrants to select investors, likely to raise capital for its operations.

For investors, this development signals that the company is seeking to bolster its financial resources. Fully convertible warrants are a hybrid instrument that can be converted into equity shares at a later date, which could impact the company's shareholding structure.

Investors should monitor the conversion timing and the use of the raised funds. Keeping an eye on the company's future announcements regarding these warrants will provide clarity on how this capital infusion might affect its business trajectory.